The arginine paradox

Folia Pharmacologica Japonica

Volumn 119, Issue 1, 2002, Pages 7-14

  Nakaki, Toshio ^a   Hishikawa, Keiichi ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hypotension; L arginine administration; L citrulline; Nitric oxide

Indexed keywords

AGMATINE; ARGININE; ARGININOSUCCINIC ACID; CITRULLINE; INSULIN; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

AMINO ACID TRANSPORT; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME KINETICS; HUMAN; INSULIN RELEASE; MEMBRANE TRANSPORT; REVIEW; VASODILATATION;

ANIMALS; ARGININE; HUMANS; NITRIC OXIDE SYNTHASE;

EID: 0036154294     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.119.7     Document Type: Review

References (58)

1. L-Arginine-induced hypotension
2. L-Arginine-induced hypotension
3. Role of L-arginine-nitric oxide pathway in hypertension
4. Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man
5. Urinary NO3- excretion as an indicator of nitric oxide formation in vivo during oral administration of L-arginine or L-NAME in rats
6. The hypotensive effect of L-arginine is associated with increased expired nitric oxide in humans
7. Stimulation of endogenous nitric oxide pathway by L-arginine reduces declamp mortality and attenuates hypertension associated with aortic cross-clamp-induced hindlimb ischemia in rats
8. L-Arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle
9. Formation of free nitric oxide from L-arginine by nitric oxide synthase: Direct enhancement of generation by superoxide dismutase
10. L-Arginine, a nitric oxide precursor, attenuates ischemia-reperfusion injury by inhibiting inositol-1,4,5-triphosphate
11. Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment
12. Supplemental dietary arginine enhances wound healing in normal but not inducible nitric oxide synthase knockout mice
13. Renal and systemic effects of aminoacids administered separately: Comparison between L-arginine and non-nitric oxide donor aminoacids
14. L-Arginine dilates rat pial arterioles by nitric oxidedependent mechanisms and increases blood flow during focal cerebral ischaemia
15. Mono-L-arginine-containing compounds dilate piglet pial arterioles via an endothelium-derived relaxing factor-like substance
16. Basic polyamino acids rich in arginine, lysine, or ornithine cause both enhancement of and refractoriness to formation of endothelium-derived nitric oxide in pulmonary artery and vein
17. L-Arginine augments endothelium-dependent vasodilation in cholesterol- fed rabbits
18. Beneficial circulatory effect of L-arginine
19. Effects of changing the availability of the substrate for nitric oxide synthase by L-arginine administration on coronary vasomotor tone in angina patients with angiographically narrowed and in patients with normal coronary arteries
20. Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production: Key role of L-arginine availability
21. Relationship between NO synthesis, arginine transport, and intracellular arginine levels in vascular smooth muscle cells
22. + arginine transport capacity in differentiating human intestinal Caco-2 cells
23. Inducible cytosolic enzyme activity for the production of nitrogen oxides from L-arginine in hepatocytes
24. 2+
25. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitricoxide synthase may explain the "arginine paradox"
26. L-Arginine availability determines the duration of acetylcholine-induced systemic vasodilation in vivo
27. Selective stimulation of L-arginine uptake contributes to shear stress-induced formation of nitric oxide
28. Effects of NG-monomethyl-L-arginine and L-arginine on acetylcholine renal response
29. Cultured endothelial cells maintain their L-arginine level despite the continuous release of EDRF
30. Nitric oxide generation from L-arginine is required for optimal human peripheral blood lymphocyte DNA synthesis
31. L-Arginine-dependent vascular smooth muscle relaxation and cGMP formation
32. Identification of system y + L as the high-affinity transporter for L-arginine in human platelets: Up-regulation of L-arginine influx in uraemia
33. Deficiency of endogenous arginine synthesis provokes hypertension by exhausting substrate arginine for nitric oxide synthesis
34. L-Arginine and nitric oxide-related compounds in plasma: Comparison of normal and arginine-free diets in a 24-h crossover study
35. Vascular endothelial dysfunction resulting from L-arginine deficiency in a patient with lysinuric protein intolerance
36. Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure
37. Arginine blocks gap junctions between retinal horizontal cells
38. Increase of nitric oxide production by L-arginine potentiates i.c.v. administered beta-endorphin-induced antinociception in the mouse
39. Arginine availability controls the N-methyl-D-aspartate-induced nitric oxide synthesis: Involvement of a glial-neuronal arginine transfer
40. High concentration of L-arginine suppresses nitric oxide synthase activity and produces reactive oxygen species in NB 9 human neuroblastoma cells
41. Growth hormone and insulin release after arginine: Indifference to hyperglycemia and epinephrine
42. Insulin vasodilatation and the "arginine paradox"
43. A novel nonenzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D-or L-arginine
44. The role of nitric oxide in L-arginine-stimulated growth hormone release
45. Effects of guanidino and uremic compounds on nitric oxide pathways
46. Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase
47. G-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients
48. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease
49. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure
50. Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells
51. Endogenous nitric oxide synthase inhibitor: A novel marker of atherosclerosis
52. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension
53. Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia
54. Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox
55. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine
56. Effects of argininosuccinic acid on nitric oxide-mediated relaxations in rat aorta and anococcygeus muscle
57. Insulin and the arginine paradox
58. Purification and inhibitor screening of human nitric oxide synthase isozymes